Monash Technology Precinct

Monash Clayton resides within the Monash Technology Precinct, a globally recognised centre for industry, research and education collaboration, creating leading-edge solutions to improve human health.

The Precinct will soon add the Moderna mRNA production facility, the first of its kind in the Southern Hemisphere, securing access to mRNA vaccines and enhancing medical research and development in Australia. The facility will be complemented by the Monash Centre for Advanced mRNA Medicine Manufacturing and Workforce Training,  which Monash is establishing in partnership with the Victorian Government.

In 2023, the operational opening of Australia’s first dedicated heart health and research hospital, the Victorian Heart Hospital, will continue to expand the unique capabilities and impact of the Monash Technology Precinct.

This Precinct offers an ecosystem of innovation that combines Monash know-how with knowledge-based industries, commercial partners and research powerhouses. It is Victoria’s largest employment hub outside the Melbourne CBD, contributing nearly $10 billion to the Victorian economy annually.

The precinct includes: